Diagnosing von Willebrand disease: A large reference laboratory's perspective

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 5, 2006, Pages 472-479

  Adcock, Dorothy M ^a   Bethel, Melissa ^a   Valcour, Andre ^b  

^a Esoterix Inc   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

Collagen binding assay; Ristocetin cofactor assay; Von Willebrand disease (vWD); Von Willebrand factor (vWF); vWF multimers

Indexed keywords

COLLAGEN; POLYMER; RISTOCETIN; VON WILLEBRAND FACTOR;

ALGORITHM; ARTICLE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EVALUATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING; RETROSPECTIVE STUDY; VON WILLEBRAND DISEASE;

COLLAGEN; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; REFERENCE VALUES; RETROSPECTIVE STUDIES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33746597868     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947860     Document Type: Article

References (29)

1. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-174
2. Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001;86:144-148
3. Sadler JE. von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003;101(6):2089-2093
4. Montgomery RR. Structure and function of von Willebrand factor. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis Basic Principles & Clinical Practice. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:249-274
5. Ruggeri ZM, Zimmerman TS. Von Willebrand factor and von Willebrand disease. Blood 1987;70:895-901
6. Favaloro EJ. von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey. Semin Thromb Hemost 2002;28:191-202
7. Marlar RA, Adcock DM, Arkin CF, et al. Assays of von Willebrand factor antigen and ristocetin cofactor activity; approved guideline. NCCLS document H51-A [ISBN 1-56238-473-2]. 2002
8. Favaloro EJ, Bonar R, Sioufi J, et al. Laboratory diagnosis of von Willebrand disorder. Am J Clin Pathol 2003;119:882-893
9. Rodgers SE, Lerda NV, Favaloro EJ, et al. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods. Am J Clin Pathol 2002;118(2):269-276
10. Favaloro EJ, Smith J, Petinos P, et al. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thromb Haemost 1999;82:1276-1282
11. Favaloro EJ, Aboud M, Arthur C. Possibility of potential vWD misdiagnosis or misclassification using LIA technology and due to the presence of rheumatoid factor. Am J Hematol 2001;66:53-56
12. Turecek PL, Siekmann J, Schwarz HP. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor. Semin Thromb Hemost 2002;28(2):149-159
13. Favaloro EJ. Laboratory identification of von Willebrand Disease: technical and scientific perspectives. Semin Thromb Hemost 2006;32:456-471
14. Favaloro EJ. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrand disease and discrimination of vWD subtypes, depends on collagen source. Thromb Haemost 2000;83:127-135
15. Raines G, Aumann H, Sykes S, Street A. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. Thromb Res 1990;60:201-212
16. Aihara M, Sawada Y, Ueno K, et al. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemost 1986;55:263-267
17. Mannucci PM, Abildgaard CF, Gralnick HR, et al. Multicenter comparison of von Willebrand factor multimer sizing techniques. Thromb Haemost 1985;54(4):873-877
18. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994;71(4):520-525
19. Schneppenheim R. The evolving classification of von Willebrand disease. Blood Coagul Fibrinolysis 2005;16(suppl 1):S3-S10
20. Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001;97(7):1915-1919
21. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004;351:683-694
22. Berntorp E, Petrini P. Long-term prophylaxis in von Willebrand disease. Blood Coagul Fibrinolysis 2005;16 (suppl 1):S23-S26
23. Favaloro EJ, Bonar R, Kershaw G, et al. Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates. Lab Hematol 2005;11:91-97
24. Casonato A, Pontara E, Bertomoro A, et al. von Willebrand factor Collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? Br J Haematol 2001;112:578-583
25. Riddell AF, Jenkins PV, Nitu-Whalley IC, et al. Use of collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay. Br J Haematol 2002;116:187-192
26. Federici AB, Canciani MT, Forza I, et al. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease. Thromb Haemost 2000;84:1127-1128
27. Favaloro EJ. A duplex issue: (i) time to re-appraise the diagnosis and classification of von Willebrand disorder, and (ii) clarification of the roles of von Willebrand factor collagen binding and ristocetin cofactor activity assays. Haemophilia 2002;8:828-831
28. Casonato A, Pontara E, Bertomoro A, et al. Which assay is the most suitable to investigate von Willebrand functional activity? Thromb Haemost 1999;81:994-995
29. Rodeghiero F, Castaman GC, Dini E. Epidemiological investigation of the presence of von Willebrand's disease. Blood 1987;69:454-459